TABLE 2.
E. coli isolate | MIC (μg/ml)
|
ESBL test resultb | Plasmidic β-lactamase gene(s) detected | Mutations in the promoter-attenuator of the ampC gene | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMP | TIC | AMC | CFZ | FOX | CAZ | CTX | CRO | IMP | ATM | ||||
A3SAEC 269-271 | >256 | >128 | 4 | >128 | 8 | 1 | 64 | 128 | 0.125 | 2 | + | blaTEM-1b + blaCTX-M-14 | No mutations |
A3SZEC 377-379 | >256 | >128 | 4 | >128 | 4 | 1 | 64 | 128 | 0.125 | 2 | + | blaCTX-M-14 | No mutations |
A3SZEC 443-445 | >256 | >128 | 8 | >128 | 4 | ≤0.5 | 32 | 128 | ≤0.06 | 2 | + | blaCTX-M-14 | No mutations |
A3YEEC 209-211 | >256 | >128 | 4 | >128 | 4 | 1 | 64 | 128 | ≤0.06 | 4 | + | blaCTX-M-14 | −18, −1, +58 |
A3SZEC 431-433 | >256 | >128 | 8 | >128 | 4 | ≤0.5 | 8 | 16 | 0.125 | 2 | + | blaTEM-1b + blaCTX-M-9 | −28, +58 |
A3AGEC 425-427 | >256 | >128 | 8 | 32 | 4 | 16 | 4 | 4 | 0.125 | 32 | + | blaTEM-1b + blaSHV-12 | No mutations |
A3SZEC 368-370 | >256 | >128 | 8 | 32 | 8 | 16 | 4 | 4 | 0.125 | 32 | + | blaTEM-1b + blaSHV-12 | +22, +26, +27, +32 |
A3LEEC 064-066 | >256 | >128 | 4 | 32 | 8 | 32 | 8 | 8 | 0.125 | 32 | + | blaSHV-12 | No mutations |
A3YEEC 296-298 | >256 | >128 | 32 | >128 | 64 | 8 | 8 | 16 | 0.125 | 8 | − | blaTEM-1b + blaCMY-2 | No mutations |
A3AAEC 031-033 | 256 | 64 | 64 | >128 | 64 | 2 | 8 | 16 | 0.125 | 4 | − | blaCMY-2 | No mutations |
A3SAEC 239-241 | >256 | >128 | 32 | 32 | 16 | 2 | 1 | 0.5 | 0.125 | 2 | − | blaTEM-1b | −42, −18, −1, +58 |
A3AVEC 404-406 | 256 | 32 | 64 | 32 | 16 | 2 | 2 | 0.5 | 0.125 | 2 | − | No bla genes detected | −42, −18, −1, +58 |
A3COEC 551-553 | 128 | 32 | 32 | 16 | 16 | 2 | 1 | 0.5 | 0.125 | 2 | − | No bla genes detected | −42, −18, −1, +58 |
AMP: ampicillin; TIC: ticarcillin; AMC: amoxicillin-clavulanic acid; CFZ: cefazolin; FOX: cefoxitin; CAZ: ceftazidime; CTX: cefotaxime; CRO: ceftriaxone; IMP: imipenem; ATM: aztreonam.
+, positive; −, negative.